Elgethun Capital Management Merck & Co., Inc. Transaction History

Elgethun Capital Management

$385 Million
Q3 2024

A detailed history of Elgethun Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Elgethun Capital Management holds 12,056 shares of MRK stock, worth $1.2 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

12,056

Previous 12,134 0.64%

Holding current value

$1.2 Million

Previous $1.5 Million 8.85%

% of portfolio

0.36%

Previous 0.42%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $8,669 - $10,059	-78 Reduced 0.64%	12,056 $1.37 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $9,408 - $10,104	-76 Reduced 0.62%	12,134 $1.5 Million
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $580,468 - $676,375	5,126 Added 72.36%	12,210 $1.61 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $448,347 - $497,907	4,355 Added 159.58%	7,084 $729,000
Q2 2023 Aug 10, 2023	BUY	$108.61 - $118.38 $1,303 - $1,420	12 Added 0.44%	2,729 $314,000
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $1,338 - $1,493	13 Added 0.48%	2,717 $289,000
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $3,672 - $4,708	42 Added 1.58%	2,704 $299,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $3.19 Million - $3.58 Million	-37,744 Reduced 93.41%	2,662 $229,000
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $44,583 - $50,537	-534 Reduced 1.3%	40,406 $3.7 Million
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $32,711 - $36,668	445 Added 1.1%	40,940 $3.36 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $161,039 - $201,723	-2,228 Reduced 5.21%	40,495 $3.1 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $56,698 - $62,354	-791 Reduced 1.82%	42,723 $3.21 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $2.38 Million - $2.63 Million	33,807 Added 348.27%	43,514 $3.38 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $89,173 - $105,037	1,295 Added 15.39%	9,707 $748,000
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $69,401 - $77,021	967 Added 12.99%	8,412 $688,000
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $4,929 - $5,609	70 Added 0.95%	7,445 $511,000
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $120,764 - $167,384	-1,906 Reduced 20.54%	7,375 $567,000
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $1,551 - $1,750	-20 Reduced 0.22%	9,281 $844,000
Q3 2019 Nov 08, 2019	BUY	$76.08 - $82.93 $49,452 - $53,904	650 Added 7.51%	9,301 $783,000
Q1 2019 May 08, 2019	BUY	$69.58 - $79.36 $3,479 - $3,968	50 Added 0.58%	8,651 $720,000
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $33,011 - $38,309	-506 Reduced 5.56%	8,601 $652,000
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $20,332 - $23,888	400 Added 4.59%	9,107 $550,000
Q1 2018 May 11, 2018	BUY	$50.96 - $59.23 $41,124 - $47,798	807 Added 10.22%	8,707 $474,000
Q4 2017 Feb 12, 2018	SELL	$51.62 - $61.64 $2,787 - $3,328	-54 Reduced 0.68%	7,900 $445,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $466,661 - $502,136	7,954	7,954 $509,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Elgethun Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Elgethun Capital Management with notifications on news.

Account

Elgethun Capital Management Merck & Co., Inc. Transaction History